Australia markets open in 3 hours 49 minutes

Concord Medical Services Holdings Limited (CCM)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
2.0500-0.0100 (-0.49%)
At close: 12:11PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.0600
Open2.0600
Bid1.6000 x 1400
Ask2.0400 x 900
Day's range2.0500 - 2.0500
52-week range1.1500 - 3.4000
Volume645
Avg. volume1,666
Market cap89.005M
Beta (5Y monthly)-0.11
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend date23 Dec 2015
1y target estN/A
  • PR Newswire

    Concord Medical Announces Its Subsidiary's Application Filing for Potential Listing on The Stock Exchange of Hong Kong Limited

    Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced that its subsidiary, Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a company incorporated in China, filed an application (the "Application") to l

  • PR Newswire

    Concord Medical Files 2021 Annual Report on Form 20-F

    Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers, premium cancer hospitals, and specialty cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2021 (the "Annual Report") with the U

  • PR Newswire

    Concord Medical Reports Financial Results for the First Half of 2021

    Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research, and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolidated financial results for the six months ended June 30, 2021[1].